Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Extracellular Matrix (ECM) Proteins and Cell-Surface Adhesion Molecules (CAMs) represent a broad functional class of molecules essential for tissue architecture and intercellular communication. The ECM consists of a complex network of macromolecules, such as collagens, proteoglycans, and glycoproteins, which provide structural support and biochemical signals to surrounding cells (Ref: PMID: 22219366). CAMs, including integrins, cadherins, and selectins, are transmembrane proteins that facilitate physical connections between cells or between a cell and the ECM, playing pivotal roles in cell signaling and migration (Ref: PMID: 11252105). In pathological states, alterations in ECM composition or CAM expression contribute to tumor metastasis, chronic inflammatory infiltration, and the development of fibrosis (Ref: PMID: 24507509). Therapeutic interventions targeting these molecules, such as monoclonal antibodies against specific integrins, are widely used to treat autoimmune disorders and prevent thrombotic events by modulating cell recruitment and adhesion (Ref: PMID: 28853167). Additionally, enzymatic targeting of the ECM is employed in conditions like Dupuytren's contracture to restore tissue flexibility (Ref: PMID: 20163212).
Inhibition of integrin-mediated cell adhesion, blockade of leukocyte extravasation, competitive inhibition of ligand binding to cell-surface receptors, and enzymatic degradation of structural matrix proteins.
6 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Extracellular Matrix Proteins and Cell-Surface Adhesion Molecules (ECM & CAMs) (ECM & CAMs).